- Home
- GV vs NERV Comparison
GV vs NERV Comparison
Compare GV & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- NERV
- Stock Information
- Founded
- GV 2013
- NERV 2007
- Country
- GV Canada
- NERV United States
- Employees
- GV N/A
- NERV N/A
- Industry
- GV Other Consumer Services
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- NERV Health Care
- Exchange
- GV Nasdaq
- NERV Nasdaq
- Market Cap
- GV 8.5M
- NERV 12.4M
- IPO Year
- GV 2022
- NERV 2014
- Fundamental
- Price
- GV $1.75
- NERV $1.59
- Analyst Decision
- GV
- NERV Hold
- Analyst Count
- GV 0
- NERV 1
- Target Price
- GV N/A
- NERV $5.00
- AVG Volume (30 Days)
- GV 105.1K
- NERV 7.7K
- Earning Date
- GV 05-20-2025
- NERV 05-20-2025
- Dividend Yield
- GV N/A
- NERV N/A
- EPS Growth
- GV N/A
- NERV N/A
- EPS
- GV N/A
- NERV 0.19
- Revenue
- GV $7,773,905.00
- NERV N/A
- Revenue This Year
- GV N/A
- NERV N/A
- Revenue Next Year
- GV N/A
- NERV N/A
- P/E Ratio
- GV N/A
- NERV $8.42
- Revenue Growth
- GV N/A
- NERV N/A
- 52 Week Low
- GV $1.00
- NERV $1.15
- 52 Week High
- GV $9.60
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- GV 36.51
- NERV 46.58
- Support Level
- GV $1.71
- NERV $1.65
- Resistance Level
- GV $1.83
- NERV $1.75
- Average True Range (ATR)
- GV 0.16
- NERV 0.08
- MACD
- GV 0.03
- NERV -0.00
- Stochastic Oscillator
- GV 13.24
- NERV 31.03
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.